Accelerate Diagnostics Inc (AXDX.O) People | Reuters.com
Edition:
United States

Accelerate Diagnostics Inc (AXDX.O)

AXDX.O on Consolidated Issue listed on NASDAQ Capital Market

16.22USD
1 Jul 2016
Change (% chg)

$1.83 (+12.72%)
Prev Close
$14.39
Open
$14.40
Day's High
$16.54
Day's Low
$14.39
Volume
465,761
Avg. Vol
253,902
52-wk High
$31.29
52-wk Low
$10.29

Summary

Name Age Since Current Position

John Patience

68 2012 Independent Chairman of the Board

Lawrence Mehren

48 2012 President, Chief Executive Officer, Director

Steve Reichling

36 2012 Chief Financial Officer

Ron Price

2015 Senior Vice President, Head - Commercial Operations

Pete Bantock

49 2015 Chief Culture Officer, Head - Human Resources

Mark Miller

60 2013 Independent Director

Jack Schuler

75 2012 Independent Director

Matthew Strobeck

42 2012 Independent Director

Frank ten Brink

58 2013 Independent Director

Biographies

Name Description

John Patience

Mr. John Patience is the Independent Chairman of the Board of Accelerate Diagnostics Inc. He has served as a Director of the Company since June 26, 2012. Mr. Patience is also a founding partner of Crabtree Partners, a private equity investment firm. Mr. Patience served as a director of Ventana Medical Systems, Inc. from 1989 and as Vice Chairman from 1999 until Ventana’s acquisition by Roche in 2008. Mr. Patience has been a director of Stericycle, Inc. (NASDAQ: SRCL) since 1989. Mr. Patience was previously a partner of a venture capital investment firm that provided both Ventana and Stericycle with early stage funding. Mr. Patience was also previously a partner in the consulting firm of McKinsey & Co., Inc., specializing in health care. Mr. Patience holds a B.A. in Liberal Arts and an L.L.B. from the University of Sydney, Australia, and an M.B.A. from the University of Pennsylvania’s Wharton School of Business.

Lawrence Mehren

Mr. Lawrence Mehren is President, Chief Executive Officer, Director of Accelerate Diagnostics Inc. He has served as the Chief Executive Officer and a Director of the Company since June 26, 2012. Mr. Mehren served as Senior Vice President and Chief Financial Officer of Ventana Medical Systems from 2007 until 2008, Senior Vice President of Emerging Businesses from 2008 until 2009 and as Head of Global Business from 2009 until 2011. Previously, he was Managing Director, Partner and head of P&M Corporate Finance’s (an investment banking firm based in Detroit, Michigan) life sciences practice. Prior to his tenure at P&M, Mr. Mehren worked in management positions with Gale Group, a division of The Thomson Corporation, as well as Merrill Lynch. Mr. Mehren holds a B.A. in Political Science from the University of Arizona and an M.B.A. from Northwestern University’s Kellogg Graduate School of Management.

Steve Reichling

Mr. Steve Reichling is Chief Financial Officer of Accelerate Diagnostics Inc., since September 10, 2012. Prior to joining the Company, Mr. Reichling served as general manager of Spring Bioscience Corp., a R&D and research products subsidiary of Roche Tissue Diagnostics. From January 2003 to December 2009, Mr. Reichling held various finance, accounting and operations leadership roles at Roche Tissue Diagnostics and Ventana Medical Systems, Inc., including director of finance and operations, manager of business development finance, and head of Internal Audit and Sarbanes Oxley Compliance. From October 2002 to January 2003, Mr. Reichling was an auditor at Ernst & Young LLP. Mr. Reichling received his B.A. in accounting and entrepreneurship from the University of Arizona and is a Certified Public Accountant.

Ron Price

Mr. Ron Price is Senior Vice President, Head - Commercial Operations of the Company. Mr. Price brings over 20 years of commercial operations experience, including experience leading sales and marketing teams to achieve double-digit revenue growth and strong bottom-line performance, to the Company. He joins the Company from Roche Diagnostics where he held the position of Vice President, Point of Care, Commercial Operations. Previously, Mr. Price held a number of leadership positions with Ventana Medical Systems and Bayer.

Pete Bantock

Mr. Pete Bantock is Chief Culture Officer, Head - Human Resources of Accelerate Diagnostics, Inc. Prior to joining the Company, Mr. Bantock was Senior Vice President and General Manager of Ventana Medical Systems’ North American Commercial Operations. Previously, he was the General Manager of Spring Bioscience, a subsidiary of Ventana/Roche. Prior to his role for Spring Bioscience, Mr. Bantock held various sales and marketing positions at Ventana Medical Systems, including Director of Marketing and Head of Corporate Accounts. Mr. Bantock began his career in diagnostics at Abbott Laboratories, where he was manager of the South African commercial operations for the Diagnostics Division. Mr. Bantock received a B.A. Degree and a Higher Diploma of Education from Rhodes University, South Africa.

Mark Miller

Mr. Mark C. Miller is an Independent Director of Accelerate Diagnostics, Inc. He has served as a Director of the Company since November 5, 2013. He currently serves as Executive Chairman and director of Stericycle (NASDAQ: SRCL), where he was Chief Executive Officer from 1992 to 2012 and Chairman of the Board of Directors from 2008 to 2012. Prior to joining Stericycle, Mr. Miller served as vice president for the Pacific, Asia and Africa in the international division of Abbott Laboratories, a diversified health care company, which he joined in 1976 and where he held a number of management and marketing positions. Mr. Miller formerly served as a director of Ventana Medical Systems, Inc., a developer and supplier of automated diagnostic systems. He received a B.S. degree in computer science from Purdue University, where he graduated Phi Beta Kappa. Mr. Miller was selected by Morningstar, Inc. as its “2009 CEO of the Year.”

Jack Schuler

Mr. Jack W. Schuler is an Independent Director of Accelerate Diagnostics Inc., since June 26, 2012. He has served as a Director of the Company since June 26, 2012. Mr. Schuler is a founding partner of Crabtree Partners, a private equity investment firm. Mr. Schuler served as a director of Ventana Medical Systems, Inc. from 1991 and as Chairman of the Board from 1995 until Ventana’s acquisition by Roche in 2008. Mr. Schuler has been a director of Stericycle, Inc. (NASDAQ: SRCL) since March 1990, formerly serving as Chairman of the Board, and continues to serve as Lead Director for Stericyle. Prior to joining Stericycle, Inc., Mr. Schuler held various executive positions at Abbott Laboratories from December 1972 through August 1989, most recently serving as President and Chief Operating Officer. He is currently a director of Quidel Corporation (NASDAQ: QDEL) and Hansen Medical, Inc. (NASDAQ: HNSN). Mr. Schuler holds a B.S. in Mechanical Engineering from Tufts University and an M.B.A. from Stanford University.

Matthew Strobeck

Dr. Matthew W. Strobeck, Ph.D., is an Independent Director of Accelerate Diagnostics Inc., since July 7, 2012. He has served as a Director of the Company since July 7, 2012. Dr. Strobeck is currently the Managing Partner of Birchview Capital. Dr. Strobeck was a Partner and Member of the Management Committee and Advisory Board of Westfield Capital Management from 2008 until 2011, having served as a member of the investment team, specializing in healthcare and life sciences, from May 2003 to June 2008. Dr. Strobeck received his B.S. from St. Lawrence University, a Ph.D. from the University of Cincinnati, a S.M. from the Harvard University/MIT Health Sciences Technology Program, and a S.M. from the MIT Sloan School of Management.

Frank ten Brink

Mr. Frank J. M. ten Brink is the Independent Director of Accelerate Diagnostics, Inc., effective March 6, 2013. He has served as a Director of the Company since March 6, 2013. Mr. ten Brink currently serves as Senior Vice President of Mergers and Acquisitions at Stericycle, Inc. (NASDAQ: SRCL) where he also served as Executive Vice President, Chief Financial Officer and Chief Administrative Officer from June 1997 to August 2014. He has over 16 years of finance experience in high growth environments, mergers and acquisitions. Prior to joining Stericycle, he was Senior Vice President and Chief Financial Officer with Telular Corporation. Between 1991 and 1995, he was Vice President and Chief Financial Officer of Hexacomb Corporation. Mr. ten Brink studied International Business at the Netherlands School of Business and received an M.B.A. degree in Finance from the University of Oregon.

Basic Compensation